Enzo Biochem (id:10148 ENZ)
0.970 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 7:25:38 PM)
Exchange closed, opens in 14 hours 4 minutes
About Enzo Biochem
Market Capitalization 54.33M
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company also licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.
Headquarters (address) |
21 Executive Blvd Farmingdale 11735 NY United States |
Phone | 631 755 5500 |
Website | https://www.enzo.com |
Employees | 125 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Ticker | ENZ |
Exchange | New York Stock Exchange |
Currency | USD |
52 week range | 0.970 - 1.50 |
Market Capitalization | 54.33M |
Dividend yield forward | 39.60 % |
Dividend yield forward United States (ID:6, base:1863) | 4.21 % |
P/E forward | -2.67 |
Price/Sale | 1.70 |
Price/Book | 0.968 |
Beta | 0.729 |
EPS | -0.190 |
EPS United States (ID:6, base:3395) | 24.30 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Enzo Biochem has raised their dividend 39.60 years in a row. This is below the 41124.611400 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Enzo Biochem has raised their dividend 39.60 years in a row. This is below the 41124.611400 year average in the 'Diagnostics & Research' industry